Arteriosclerosis, Vol 8, 737-741, Copyright © 1988 by American Heart Association

ARTICLES

High density lipoprotein cholesterol and mortality. The Framingham Heart Study

PW Wilson, RD Abbott and WP Castelli
Framingham Epidemiology Research Section, NHLBI, Massachusetts.

In 12 years of follow-up for 2748 Framingham Heart Study participants ages 50 to 79, low levels of high density lipoprotein cholesterol (HDL- C) were associated with increased mortality. For men, the relative risk of death in the first HDL-C quintile (less than 35 mg/dl) as compared to the top quintile (greater than 54 mg/dl) was 1.9 for all causes, and 3.6 and 4.1 for death due to cardiovascular and coronary heart disease (CHD), respectively, after adjustment for standard cardiovascular risk factors. In women, corresponding relative risks, comparing the bottom HDL-C quintile (less than 45 mg/dl) to the top quintile (greater than 69 mg/dl), were 1.5, 1.6, and 3.1. With HDL-C considered as a continuous variable, and after adjustment for standard cardiovascular risk factors, highly significant associations were seen with HDL-C and CHD death in both men and women. In addition, a significant HDL-C effect on total mortality and death due to cardiovascular disease was seen in men. In none of the continuous variable analyses was HDL-C associated with cancer death. We conclude that HDL-C is a potent predictor of CHD death in both sexes and has less consistent associations with other types of death.

This article has been cited by other articles:

				N. P. Visavadiya and A. V. R. L. Narasimhacharya Asparagus Root Regulates Cholesterol Metabolism and Improves Antioxidant Status in Hypercholesteremic Rats Evid. Based Complement. Altern. Med., June 1, 2009; 6(2): 219 - 226. [Abstract] [Full Text] [PDF]

				N. Goldman, D. A. Glei, Y.-H. Lin, and M. Weinstein Improving Mortality Prediction Using Biosocial Surveys Am. J. Epidemiol., March 15, 2009; 169(6): 769 - 779. [Abstract] [Full Text] [PDF]

				M. Y. Tsai, N. Li, A. R. Sharrett, S. Shea, D. R. Jacobs Jr, R. Tracy, D. Arnett, V. Arends, and W. Post Associations of Genetic Variants in ATP-Binding Cassette A1 and Cholesteryl Ester Transfer Protein and Differences in Lipoprotein Subclasses in the Multi-Ethnic Study of Atherosclerosis Clin. Chem., March 1, 2009; 55(3): 481 - 488. [Abstract] [Full Text] [PDF]

				C. Pitsavos, D. B. Panagiotakos, J. Skoumas, L. Papadimitriou, and C. Stefanadis Risk Stratification of Apolipoprotein B, Apolipoprotein A1, and Apolipoprotein B/AI Ratio on the Prevalence of the Metabolic Syndrome: the ATTICA Study Angiology, July 1, 2008; 59(3): 335 - 341. [Abstract] [PDF]

				R. Movva and D. J. Rader Laboratory Assessment of HDL Heterogeneity and Function Clin. Chem., May 1, 2008; 54(5): 788 - 800. [Abstract] [Full Text] [PDF]

				P. M. Janiszewski, T. J. Saunders, and R. Ross Themed Review: Lifestyle Treatment of the Metabolic Syndrome American Journal of Lifestyle Medicine, April 1, 2008; 2(2): 99 - 108. [Abstract] [PDF]

				T. J. F. Nieland, J. T. Shaw, F. A. Jaipuri, Z. Maliga, J. L. Duffner, A. N. Koehler, and M. Krieger Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI J. Lipid Res., August 1, 2007; 48(8): 1832 - 1845. [Abstract] [Full Text] [PDF]

				H. Berrougui, M. Isabelle, M. Cloutier, G. Grenier, and A. Khalil Age-related impairment of HDL-mediated cholesterol efflux J. Lipid Res., February 1, 2007; 48(2): 328 - 336. [Abstract] [Full Text] [PDF]

				M. Okazaki, S. Usui, A. Fukui, I. Kubota, and H. Tomoike Component Analysis of HPLC Profiles of Unique Lipoprotein Subclass Cholesterols for Detection of Coronary Artery Disease Clin. Chem., November 1, 2006; 52(11): 2049 - 2053. [Abstract] [Full Text] [PDF]

				H. Drexel Reducing risk by raising HDL-cholesterol: the evidence Eur. Heart J. Suppl., October 1, 2006; 8(suppl_F): F23 - F29. [Abstract] [Full Text] [PDF]

				M. J. Chapman How does nicotinic acid modify the lipid profile? Eur. Heart J. Suppl., October 1, 2006; 8(suppl_F): F54 - F59. [Abstract] [Full Text] [PDF]

				A. J. Taylor Evidence to support aggressive management of HDL-cholesterol: implications of recent trials Eur. Heart J. Suppl., October 1, 2006; 8(suppl_F): F74 - F80. [Abstract] [Full Text] [PDF]

				N. N. Thu, T. T. T. Mai, R. Ohmori, M. Kuroki, N. V. Chuyen, N. T. K. Hung, M. Kawakami, and K. Kondo Plasma Triglyceride and HDL-Cholesterol Concentrations in Vietnamese Girls Are Affected by Lipoprotein Lipase, but Not Apolipoprotein CIII Polymorphism J. Nutr., June 1, 2006; 136(6): 1488 - 1492. [Abstract] [Full Text] [PDF]

				M. Van Eck, R. R. Singaraja, D. Ye, R. B. Hildebrand, E. R. James, M. R. Hayden, and T. J.C. Van Berkel Macrophage ATP-Binding Cassette Transporter A1 Overexpression Inhibits Atherosclerotic Lesion Progression in Low-Density Lipoprotein Receptor Knockout Mice Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 929 - 934. [Abstract] [Full Text] [PDF]

				J. M Ordovas Genetic interactions with diet influence the risk of cardiovascular disease Am. J. Clinical Nutrition, February 1, 2006; 83(2): 443S - 446S. [Abstract] [Full Text] [PDF]

				M. D. Ashen and R. S. Blumenthal Low HDL Cholesterol Levels N. Engl. J. Med., September 22, 2005; 353(12): 1252 - 1260. [Full Text] [PDF]

				A. M. Vaughan and J. F. Oram ABCG1 Redistributes Cell Cholesterol to Domains Removable by High Density Lipoprotein but Not by Lipid-depleted Apolipoproteins J. Biol. Chem., August 26, 2005; 280(34): 30150 - 30157. [Abstract] [Full Text] [PDF]

				A. Veiraiah Hyperglycemia, Lipoprotein Glycation, and Vascular Disease Angiology, July 1, 2005; 56(4): 431 - 438. [Abstract] [PDF]

				P. Barter The role of HDL-cholesterol in preventing atherosclerotic disease Eur. Heart J. Suppl., July 1, 2005; 7(suppl_F): F4 - F8. [Abstract] [Full Text] [PDF]

				J. Shepherd Raising HDL-cholesterol and lowering CHD risk: does intervention work? Eur. Heart J. Suppl., July 1, 2005; 7(suppl_F): F15 - F22. [Abstract] [Full Text] [PDF]

				J. J.P. Kastelein The realities of dyslipidaemia: what do the studies tell us? Eur. Heart J. Suppl., July 1, 2005; 7(suppl_F): F27 - F33. [Abstract] [Full Text] [PDF]

				B. G. Brown Maximizing coronary disease risk reduction using nicotinic acid combined with LDL-lowering therapy Eur. Heart J. Suppl., July 1, 2005; 7(suppl_F): F34 - F40. [Abstract] [Full Text] [PDF]

				J. Chapman Beyond LDL-cholesterol reduction: the way ahead in managing dyslipidaemia Eur. Heart J. Suppl., July 1, 2005; 7(suppl_F): F56 - F62. [Abstract] [Full Text] [PDF]

				P. S. Woll, N. Q. Hanson, V. L. Arends, and M. Y. Tsai Effect of Two Common Polymorphisms in the ATP Binding Cassette Transporter A1 Gene on HDL-Cholesterol Concentration Clin. Chem., May 1, 2005; 51(5): 907 - 909. [Full Text] [PDF]

				M. Okazaki, S. Usui, M. Ishigami, N. Sakai, T. Nakamura, Y. Matsuzawa, and S. Yamashita Identification of Unique Lipoprotein Subclasses for Visceral Obesity by Component Analysis of Cholesterol Profile in High-Performance Liquid Chromatography Arterioscler Thromb Vasc Biol, March 1, 2005; 25(3): 578 - 584. [Abstract] [Full Text] [PDF]

				P. Barter The realities of dyslipidaemia in metabolic syndrome and diabetes The British Journal of Diabetes & Vascular Disease, January 1, 2005; 5(1_suppl): S7 - S11. [Abstract] [PDF]

				M. Marchesi, E. A. Booth, T. Davis, C. L. Bisgaier, and B. R. Lucchesi Apolipoprotein A-IMilano and 1-Palmitoyl-2-oleoyl Phosphatidylcholine Complex (ETC-216) Protects the in Vivo Rabbit Heart from Regional Ischemia-Reperfusion Injury J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1023 - 1031. [Abstract] [Full Text] [PDF]

				S. Canizales-Quinteros, C. A. Aguilar-Salinas, E. Reyes-Rodriguez, L. Riba, M. Rodriguez-Torres, S. Ramirez-Jimenez, A. Huertas-Vazquez, V. Fragoso-Ontiveros, A. Zentella-Dehesa, J. L. Ventura-Gallegos, et al. Locus on Chromosome 6p Linked to Elevated HDL Cholesterol Serum Levels and to Protection Against Premature Atherosclerosis in a Kindred With Familial Hypercholesterolemia Circ. Res., March 21, 2003; 92(5): 569 - 576. [Abstract] [Full Text] [PDF]

				P. S. Woll, N. Q. Hanson, and M. Y. Tsai Absence of ABCA1 Mutations in Individuals with Low Serum HDL-Cholesterol Clin. Chem., March 1, 2003; 49(3): 521 - 522. [Full Text] [PDF]

				A Cenarro, M Artieda, S Castillo, P Mozas, G Reyes, D Tejedor, R Alonso, P Mata, M Pocovi, and F Civeira A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia J. Med. Genet., March 1, 2003; 40(3): 163 - 168. [Abstract] [Full Text] [PDF]

				O. Wiklund Treating lipids in cardiovascular disease: new directions Eur. Heart J. Suppl., May 1, 2001; 3(suppl_B): B27 - B31. [Abstract] [PDF]

				D. W. Garber, G. Datta, M. Chaddha, M. N. Palgunachari, S. Y. Hama, M. Navab, A. M. Fogelman, J. P. Segrest, and G. M. Anantharamaiah A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis J. Lipid Res., April 1, 2001; 42(4): 545 - 552. [Abstract] [Full Text]

				S. M. Clee, A. H. Zwinderman, J. C. Engert, K. Y. Zwarts, H. O. F. Molhuizen, K. Roomp, J. W. Jukema, M. van Wijland, M. van Dam, T. J. Hudson, et al. Common Genetic Variation in ABCA1 Is Associated With Altered Lipoprotein Levels and a Modified Risk for Coronary Artery Disease Circulation, March 6, 2001; 103(9): 1198 - 1205. [Abstract] [Full Text] [PDF]

				S. B. Harrap, M. Stebbing, J. L. Hopper, H. N. Hoang, and G. G. Giles Familial Patterns of Covariation for Cardiovascular Risk Factors in Adults: The Victorian Family Heart Study Am. J. Epidemiol., October 15, 2000; 152(8): 704 - 715. [Abstract] [Full Text] [PDF]

				S. Usui, M. Nakamura, K. Jitsukata, M. Nara, S. Hosaki, and M. Okazaki Assessment of Between-Instrument Variations in a HPLC Method for Serum Lipoproteins and Its Traceability to Reference Methods for Total Cholesterol and HDL-Cholesterol Clin. Chem., January 1, 2000; 46(1): 63 - 72. [Abstract] [Full Text] [PDF]

				K. Kusterer, T. Pohl, H.-P. Fortmeyer, W. Marz, H. Scharnagl, A. Oldenburg, S. Angermuller, I. Fleming, K. H. Usadel, and R. Busse Chronic selective hypertriglyceridemia impairs endothelium-dependent vasodilatation in rats Cardiovasc Res, June 1, 1999; 42(3): 783 - 793. [Abstract] [Full Text] [PDF]

				W. Velez-Carrasco, A. H. Lichtenstein, F. K. Welty, Z. Li, S. Lamon-Fava, G. G. Dolnikowski, and E. J. Schaefer Dietary Restriction of Saturated Fat and Cholesterol Decreases HDL ApoA-I Secretion Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 918 - 924. [Abstract] [Full Text] [PDF]

				M. Nauck, W. Marz, and H. Wieland New immunoseparation-based homogeneous assay for HDL-cholesterol compared with three homogeneous and two heterogeneous methods for HDL-cholesterol Clin. Chem., July 1, 1998; 44(7): 1443 - 1451. [Abstract] [Full Text] [PDF]

				S. M. Grundy, G. J. Balady, M. H. Criqui, G. Fletcher, P. Greenland, L. F. Hiratzka, N. Houston-Miller, P. Kris-Etherton, H. M. Krumholz, J. LaRosa, et al. Primary Prevention of Coronary Heart Disease: Guidance From Framingham : A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction Circulation, May 19, 1998; 97(18): 1876 - 1887. [Full Text] [PDF]

				P. Cullen, H. Schulte, and G. Assmann The Munster Heart Study (PROCAM) : Total Mortality in Middle-Aged Men Is Increased at Low Total and LDL Cholesterol Concentrations in Smokers but Not in Nonsmokers Circulation, October 7, 1997; 96(7): 2128 - 2136. [Abstract] [Full Text]

				M. Nauck, W. Marz, J. Jarausch, C. Cobbaert, A. Sagers, D. Bernard, J. Delanghe, G. Honauer, P. Lehmann, E. Oestrich, et al. Multicenter evaluation of a homogeneous assay for HDL-cholesterol without sample pretreatment Clin. Chem., September 1, 1997; 43(9): 1622 - 1629. [Abstract] [Full Text] [PDF]

				J. M. Hoeg Can Genes Prevent Atherosclerosis? JAMA, September 25, 1996; 276(12): 989 - 992. [Abstract] [PDF]

				M. Paunio, J. Virtamo, C.-G. Gref, and O. P Heinonen Serum high density lipoprotein cholesterol, alcohol, and coronary mortality in male smokers BMJ, May 11, 1996; 312(7040): 1200 - 1203. [Abstract] [Full Text]

				M.-C. Corti, J. M. Guralnik, M. E. Salive, T. Harris, T. S. Field, R. B. Wallace, L. F. Berkman, T. E. Seeman, R. J. Glynn, C. H. Hennekens, et al. HDL Cholesterol Predicts Coronary Heart Disease Mortality in Older Persons JAMA, August 16, 1995; 274(7): 539 - 544. [Abstract] [PDF]

				P. F. Kokkinos, J. C. Holland, P. Narayan, J. A. Colleran, C. O. Dotson, and V. Papademetriou Miles Run per Week and High-Density Lipoprotein Cholesterol Levels in Healthy, Middle-aged Men: A Dose-Response Relationship Arch Intern Med, February 27, 1995; 155(4): 415 - 420. [Abstract] [PDF]

				H. B. Rubins, G. Schectman, T. J. Wilt, and M. K. Iwane Distribution of Lipid Phenotypes in Community-Living Men With Coronary Heart Disease: High Prevalence of Isolated Low Levels of High-Density Lipoprotein Cholesterol Arch Intern Med, December 1, 1992; 152(12): 2412 - 2416. [Abstract] [PDF]

				J. M. McKenney, M. D. Barnett, J. T. Wright Jr, and J. P. Proctor Comparison of Gemfibrozil and Lovastatin in Patients With High Low-Density Lipoprotein and Low High-Density Lipoprotein Cholesterol Levels Arch Intern Med, September 1, 1992; 152(9): 1781 - 1787. [Abstract] [PDF]

				S. Lutucuta, C. M. Ballantyne, H. Elghannam, A. M. Gotto Jr, and A. J. Marian Novel Polymorphisms in Promoter Region of ATP Binding Cassette Transporter Gene and Plasma Lipids, Severity, Progression, and Regression of Coronary Atherosclerosis and Response to Therapy Circ. Res., May 11, 2001; 88(9): 969 - 973. [Abstract] [Full Text] [PDF]